Literature DB >> 2060561

Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

B J Lipworth1, B F Tregaskis, D G McDevitt.   

Abstract

The purpose of the study was to compare beta-adrenoceptor responsiveness to salbutamol (beta-2 selective agonist) and isoprenaline (non-selective) in young (n = 10, age 23 y) and elderly (n = 7, age 71 y) subjects. Subjects were given cumulative doubling doses of inhaled isoprenaline or salbutamol (500-4000 micrograms), and placebo, in a single-blind randomised cross-over design. Plasma potassium, electrocardiographic (R-R, T-wave, Q-Tc) and blood pressure responses were measured at baseline and at each dose step. There were no difference between baseline values for each of the three study days within each group of subjects. Hypokalaemia was significantly greater in response to salbutamol compared with isoprenaline in both the young (as change from baseline): -0.61 versus -0.10 mmol.l-1: and in the elderly: -0.68 versus -0.20 mmol.l-1. There were no differences between young and elderly responses. T-wave amplitude fell significantly in response to isoprenaline and salbutamol, although this effect was progressively attenuated with increasing doses of isoprenaline. Maximum T-wave response (change from baseline) was greater with salbutamol than isoprenaline in the young: -0.22 versus -0.11 mV: and in the elderly: -0.17 versus -0.08 mV, and there were no differences between the two groups. There were no differences between the effects of isoprenaline and salbutamol on Q-Tc prolongation or heart rate. Chronotropic responses to salbutamol were greater in the elderly: 39 versus 24 beats.min-1. There were larger increases in SBP with isoprenaline in both groups. Falls in DBP in response to isoprenaline and salbutamol were significantly greater in the elderly.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060561     DOI: 10.1007/bf00315205

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  44 in total

1.  Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; L C McFarlane; W J Coutie; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Effect of age and high blood pressure on baroreflex sensitivity in man.

Authors:  B Gribbin; T G Pickering; P Sleight; R Peto
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

Review 3.  Relationship between electrocardiogram and electrolytes.

Authors:  B Surawicz
Journal:  Am Heart J       Date:  1967-06       Impact factor: 4.749

4.  Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

5.  Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes.

Authors:  I B Abrass; P J Scarpace
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

6.  Vagal activity is increased during intravenous isoprenaline infusion in man.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

7.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  J M Arnold; P C O'Connor; J G Riddell; D W Harron; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

8.  Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.

Authors:  O E Brodde; K Karad; H R Zerkowski; N Rohm; J C Reidemeister
Journal:  Circ Res       Date:  1983-12       Impact factor: 17.367

9.  Physiological and pharmacological aspects of adrenergic receptor classification.

Authors:  E J Ariëns; A M Simonis
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

10.  The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

Authors:  A D Struthers; J L Reid; R Whitesmith; J C Rodger
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

View more
  8 in total

1.  Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?

Authors:  J G Maconochie; N A Minton; J E Chilton; O N Keene
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

Review 2.  Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.

Authors:  D M Newnham
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.

Authors:  Ken M Kunisaki; Kathryn L Rice; Dennis E Niewoehner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM).

Authors:  P Widmer; R Maibach; U P Künzi; R Capaul; U Mueller; R Galeazzi; R Hoigné
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.

Authors:  D M Newnham; N M Wheeldon; B J Lipworth; D G McDevitt
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

6.  Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.

Authors:  Daniel K C Lee; Caroline E Bates; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 7.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

8.  Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.

Authors:  A R Rahman; D G McDevitt; A D Struthers; B J Lipworth
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.